Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Merck
Express Scripts
Baxter
Chinese Patent Office
Cerilliant
Farmers Insurance
Fuji
Daiichi Sankyo

Generated: April 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020409

« Back to Dashboard

NDA 020409 describes NASAREL, which is a drug marketed by Teva Branded Pharm and is included in one NDA. Additional details are available on the NASAREL profile page.

The generic ingredient in NASAREL is flunisolide. There are twelve drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the flunisolide profile page.
Summary for 020409
Tradename:NASAREL
Applicant:Teva Branded Pharm
Ingredient:flunisolide
Patents:0
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SPRAY, METERED;NASALStrength0.029MG/SPRAY
Approval Date:Mar 8, 1995TE:RLD:No

Expired US Patents for NDA 020409

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Teva Branded Pharm NASAREL flunisolide SPRAY, METERED;NASAL 020409-001 Mar 8, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Teva Branded Pharm NASAREL flunisolide SPRAY, METERED;NASAL 020409-001 Mar 8, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Teva Branded Pharm NASAREL flunisolide SPRAY, METERED;NASAL 020409-001 Mar 8, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Fuji
Julphar
UBS
Citi
Covington
Federal Trade Commission
Johnson and Johnson
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.